We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Akoya BioSciences Inc | NASDAQ:AKYA | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.02 | -0.52% | 3.80 | 3.75 | 5.97 | 3.84 | 3.745 | 3.80 | 93,172 | 01:00:00 |
From Apr 2023 to Apr 2024
By Sabela Ojea
Shares of Akoya Biosciences on Wednesday dropped 9.2% to $5.05 in after-hours trading after the company said it fired its chief medical officer and chief people officer as part of a cost-cutting plan.
The spatial biology company said Chief Medical Officer Ehab El-Gabry, who took over the role in April 2022, and Marilee Moy, who was named the group's chief people officer in January of last year, are both entitled to receive severance payments, according to a Securities and Exchange Commission filing.
In a separate filing, the company said it is offering shares of its common stock.
Akoya Biosciences didn't, however, disclose the number of shares it is offering or the price of each share. But it noted that entities affiliated with its two largest shareholders, Telegraph Hill Partners and PSC Capital Partners, as well as some of its directors and executive officers intend to buy shares.
Write to Sabela Ojea at sabela.ojea@wsj.com
(END) Dow Jones Newswires
June 07, 2023 19:53 ET (23:53 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
1 Year Akoya BioSciences Chart |
1 Month Akoya BioSciences Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
